Comprehensive therapy for hemangioma presenting with Kasabach-Merritt syndrome in the maxillofacial region.
Su, Lixin
Comprehensive therapy for hemangioma presenting with Kasabach-Merritt syndrome in the maxillofacial region. [electronic resource] - Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons Jan 2015 - 92-8 p. digital
Publication Type: Journal Article; Observational Study
1531-5053
10.1016/j.joms.2014.07.037 doi
Blood Coagulation Tests
Combined Modality Therapy
Embolization, Therapeutic--methods
Female
Follow-Up Studies
Glucocorticoids--therapeutic use
Head and Neck Neoplasms--drug therapy
Hemangioma--drug therapy
Humans
Infant
Infant, Newborn
Kasabach-Merritt Syndrome--drug therapy
Male
Methylprednisolone--therapeutic use
Platelet Count
Polyvinyl Alcohol--therapeutic use
Propranolol--therapeutic use
Retrospective Studies
Skin Neoplasms--drug therapy
Skin Pigmentation--drug effects
Treatment Outcome
Vasodilator Agents--therapeutic use
Comprehensive therapy for hemangioma presenting with Kasabach-Merritt syndrome in the maxillofacial region. [electronic resource] - Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons Jan 2015 - 92-8 p. digital
Publication Type: Journal Article; Observational Study
1531-5053
10.1016/j.joms.2014.07.037 doi
Blood Coagulation Tests
Combined Modality Therapy
Embolization, Therapeutic--methods
Female
Follow-Up Studies
Glucocorticoids--therapeutic use
Head and Neck Neoplasms--drug therapy
Hemangioma--drug therapy
Humans
Infant
Infant, Newborn
Kasabach-Merritt Syndrome--drug therapy
Male
Methylprednisolone--therapeutic use
Platelet Count
Polyvinyl Alcohol--therapeutic use
Propranolol--therapeutic use
Retrospective Studies
Skin Neoplasms--drug therapy
Skin Pigmentation--drug effects
Treatment Outcome
Vasodilator Agents--therapeutic use